Early predictors of acute hepatitis B progression to liver failure

Autor: Yandan Zhong, Tian Xiong, Hua-Li Wang, Ping Huang, Yongfeng Yang, Qingfang Xiong
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
HBsAg
Gastroenterology and hepatology
Physiology
medicine.medical_treatment
lcsh:Medicine
Aminotransferases
Liver transplantation
Gastroenterology
Biochemistry
Hepatitis
0302 clinical medicine
Medicine and Health Sciences
Medicine
Bile
030212 general & internal medicine
lcsh:Science
Hepatic encephalopathy
Pathology and laboratory medicine
Multidisciplinary
medicine.diagnostic_test
digestive
oral
and skin physiology

Hepatitis B
Medical microbiology
Middle Aged
Prognosis
Body Fluids
Enzymes
Infectious hepatitis
HBeAg
Viruses
Acute Disease
Disease Progression
Infectious diseases
030211 gastroenterology & hepatology
Female
Pathogens
Anatomy
Research Article
Adult
medicine.medical_specialty
Hepatitis B virus
Adolescent
Acute Liver Failure
Surgical and Invasive Medical Procedures
Viral diseases
Microbiology
03 medical and health sciences
Digestive System Procedures
Young Adult
Transferases
Internal medicine
Humans
Liver diseases
Aged
Retrospective Studies
Prothrombin time
Transplantation
Biology and life sciences
business.industry
lcsh:R
Viral pathogens
Organisms
Proteins
Bilirubin
Organ Transplantation
medicine.disease
Hepatitis viruses
Liver Transplantation
Microbial pathogens
Enzymology
lcsh:Q
business
Liver Failure
Zdroj: PLoS ONE
PLoS ONE, Vol 13, Iss 7, p e0201049 (2018)
ISSN: 1932-6203
Popis: Background and aims 1~4% of acute hepatitis B (AHB) cases in adults progresses to acute liver failure (ALF).The predictors of ALF and prognosis for patients with ALF are not clear. This study investigated some of predictive and prognostic factors for AHB progression to ALF. Methods A retrospective analysis was used to assess the clinical and laboratory features of 293 patients diagnosed with AHB; the patients were divided into the following two groups: ALF (n = 13) and non-ALF (n = 280). Results In total,13 of the 293 (4.43%) patients developed ALF (10 recovered、3 died). The variables of age, anti-HBc IgM titers≥10 S/CO, HBeAg negativity, and total bilirubin (TB) at admission were significantly higher in ALF patients than in non-ALF patients. Compared to non-ALF patients, ALF patients had significantly lower values for prothrombin time activity (PTA), serum albumin, and HBV DNA. At discharge, ALF patients had lower TB normalization rates and much faster clearance of HBsAg, HBeAg and HBVDNA than non-ALF patients. In multivariate analysis, TB≥5×upper limit of normal (ULN) and HBeAg negative status were independent predictors for ALF development at admission, with 84.6% sensitivity, 85.7% specificity, a likelihood ratio of 5.91 and an area under the receiver operating characteristics curve (AUROC) of 0.850.Those who died had lower levels of peak PTA (
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje